ACTL7A inhibitors are a class of chemical compounds specifically designed to inhibit the activity of ACTL7A, a member of the actin-like protein family. ACTL7A plays a crucial role in the regulation of cytoskeletal dynamics, particularly in processes such as cellular movement, division, and intracellular trafficking. Actin-like proteins, including ACTL7A, share structural similarities with actin but often have specialized functions within cells, such as influencing the organization of the actin cytoskeleton or interacting with other cytoskeletal components. Inhibitors targeting ACTL7A typically function by binding to key domains of the protein, such as regions involved in ATP binding or actin filament interactions. These inhibitors may mimic ATP or other molecules that naturally interact with ACTL7A, competitively blocking its activity and preventing it from contributing to cytoskeletal rearrangements.
The development of ACTL7A inhibitors relies on a detailed understanding of the protein's three-dimensional structure, typically obtained through techniques such as X-ray crystallography, nuclear magnetic resonance (NMR), or cryo-electron microscopy. These structural studies reveal the specific regions of ACTL7A involved in its interaction with actin filaments or its ATPase activity, providing crucial insights for designing inhibitors that can precisely target these functional domains. Computational tools, such as molecular docking and molecular dynamics simulations, are frequently used to predict how potential inhibitors will bind to ACTL7A and to optimize their chemical properties for improved specificity and affinity. In some cases, inhibitors may also work by binding allosterically, inducing conformational changes in ACTL7A that hinder its ability to interact with other cytoskeletal proteins. By inhibiting ACTL7A, these compounds serve as valuable tools for studying the role of actin-like proteins in cellular processes, offering insights into how ACTL7A contributes to cytoskeletal regulation, cellular organization, and movement.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Stabilizes microtubules and can disrupt cytoskeletal dynamics, potentially affecting ACTL7A's role in cytoskeletal organization. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Depolymerizes microtubules and can alter microtubule dynamics, which may influence ACTL7A's function. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Binds to tubulin and inhibits microtubule polymerization, potentially impacting ACTL7A-related processes. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
Inhibits microtubule formation and can affect cell division and cytoskeletal processes involving ACTL7A. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, can affect actin cytoskeleton organization, potentially influencing ACTL7A's function. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
Inhibits myosin II ATPase activity and can affect muscle contraction and cell motility, processes that may involve ACTL7A. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Disrupts actin polymerization and can alter the actin cytoskeleton, potentially modifying ACTL7A's activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
Inhibits myosin light chain kinase (MLCK) and can impact actin-myosin contraction, which may affect ACTL7A. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
An Arp2/3 complex inhibitor and can affect actin polymerization, potentially influencing ACTL7A's role in actin filament branching. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
Inhibits formin-mediated actin assembly and can influence actin dynamics, potentially impacting ACTL7A's function. |